September 28, 2011
A New York federal judge on Wednesday dismissed antitrust counterclaims brought by drugmaker Sandoz Inc. in Bayer Schering Pharma AG's patent infringement suit over a generic version of oral contraceptive Yasmin, effectively ending the dispute.